Skip to content

Full Pulpotomy Procedure of Permanent Molar Teeth of Adults Using Calcium Silicate-based Sealer Material

Evaluation Of The Efficacy Of Using Calcium-Silicate Based Sealers As A Pulp Capping Material After Adult Pulpotomy: An In-vivo Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06504108
Enrollment
78
Registered
2024-07-16
Start date
2024-07-31
Completion date
2026-05-31
Last updated
2024-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irreversible Pulpitis

Keywords

pulpotomy, calcium silicate-based sealer, irreversible pulpitis, MTA

Brief summary

This clinical study aims to assess the efficacy of using calcium silicate based sealer as a capping material after complete removal of coronal pulp tissue. The study will evaluate both the clinical and radiographic changes.

Detailed description

Root canal treatment has always been considered the first line of treatment for carious teeth with symptomatic irreversible pulpitis for a long time. However, after the evolution of calcium silicate based materials a more conservative option, which is pulpotomy began to gain reliability, especially that it preserves the vitality of the radicular pulp, clinically simpler, less time-consuming, and more cost-effective compared to conventional root canal treatment. In this study the investigators assess the clinical and radiographic success rate of using calcium silicate based sealer as a pulp capping material in permanent molars after pulpotomy. For the best of the investigators' knowledge, there is no available clinical data on the use of calcium-silicate based sealers as a pulp capping material in pulpotomy of permanent molars with symptoms of irreversible pulpitis.

Interventions

PROCEDURECalcium silicate-based sealer full Pulpotomy

Using calcium silicate-based sealer as a capping agent after full pulpotomy

PROCEDURECalcium silicate-based premixed putty full Pulpotomy

Using calcium silicate-based premixed putty as a capping agent after full pulpotomy

Using combination between calcium silicate-based sealer and calcium silicate-based premixed putty as a capping agent after full pulpotomy

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Vital mandibular molar teeth with mature apices. * Teeth that respond positively to cold testing. * Teeth without any signs of necrosis including sinus tract or swelling. * Teeth with caries extending ≥ 2/3 of dentine or exposing the pulp. * Teeth with symptomatic irreversible pulpitis with/without apical periodontitis. * Teeth without periodontal diseases or mobility. * Teeth without root resorption, detectable pulp chamber and root canal calcification or history of trauma. * Patients from both genders with age range from 20 to 45 years old. * Patients with good or moderate oral hygiene and without any systemic diseases.

Exclusion criteria

Pre-operative criteria: * Non-vital teeth. * Teeth with irreversible pulpitis with apical periodontitis. * Teeth with immature apices. * Teeth with Periodontal disease or mobility grade II or III. * Teeth that are badly decayed and need post and core placement. * Patients refused to continue treatment procedures or refuse to commit to periodic follow-up sessions. * Non-restorable teeth. Intra-operative criteria: * If hemostasis could not be achieved within 6 minutes after full pulpotomy. * Teeth with partial necrosis. * No bleeding after access cavity preparation. Post-operative criteria: * presence of Swelling. * presence of Sinus tract. * Pain on percussion after the end of the first week. * Pain with palpation. * Pain on biting after the end of first week. * Mobility of the tooth. * Fracture of tooth structure that renders the tooth non-restorable. * Fracture of the restoration during the evaluation. * Probing depth more than 3 mm.

Design outcomes

Primary

MeasureTime frameDescription
Clinical success after full pulpotomy procedureimmediate postoperativeClinical evaluation of the targeted tooth is performed and the treatment is considered successful in case of: absence of post-operative pain, absence of pain on percussion and palpation, absence of any swelling related to the treated tooth, absence of sinus tract or fistula and absence of tooth mobility.
Radiographic success after full pulpotomy procedureimmediate postoperativeRadiographic evaluation of the targeted tooth is performed and the treatment is considered successful in case of presence of normal periodontal ligament space, absence of internal or external root resorption, absence of canal calcification, absence of peri-radicular radiolucency and no loss or break of lamina dura.
Cinical success after full pulpotomy procedureAt 3 monthsClinical evaluation of the targeted tooth is performed and the treatment is considered successful in case of: absence of post-operative pain, absence of pain on percussion and palpation, absence of any swelling related to the treated tooth, absence of sinus tract or fistula and absence of tooth mobility.

Secondary

MeasureTime frameDescription
Assessment of Post-operative pain after full pulpotomy procedure6 hours, 24 hours, 48 hours, 72 hours and 7 daysThe postoperative pain was assessed by using the modified verbal descriptor Scale (mVDS). Patients were instructed to place a mark on the horizontal scale to represent the intensity of pain experienced, furthermore, they were asked to use the verbal descriptors as a guide. The level of pain was documented at the range of 0-10 numerically and verbally as no pain (0), slight pain (1, 2), moderate pain (3-5), strong pain (6, 7), severe pain (8), and maximum pain (9, 10).

Countries

Egypt

Contacts

Primary ContactMahmoud Y Abdelsalam, Master Degree
mahmoudyahia96@gmail.com8001111111
Backup ContactMotaz M Elsadat, PhD
motazelsadat@gmail.com8002222222

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026